Wednesday, October 10, 2007 5:11:40 PM
Dara operates successfully by acquiring promising therapeutic molecules and medical technologies directly or through investment in established companies. With this unique structure and strategic model, DARA offers two avenues for returns for its investors.
DARA’s development and liquidity strategy for each entity will vary depending on market conditions, stage of development, the target profile of product candidates in the pipeline and the competitive market dynamic.
The DARA Biosciences senior management team has substantial experience in the formation of biopharmaceutical and medical device companies. They understand how the development and commercialization processes come together to build a successful pharmaceutical brand. Collectively, the leadership team has formed more than 10 companies that have launched successful products and provided a significant return to its investors.
At DARA BioSciences, we believe that our extensive due diligence process has yielded an exceptional pipeline of candidates that can alter the course of medicine and help patients in need. At DARA BioSciences, we are committed to advancing medical discoveries.
For more information about investing in DARA, please contact
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM